Rockefeller Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,100
Closed -$3K 4017
2022
Q4
$3K Hold
2,100
﹤0.01% 3508
2022
Q3
$2K Sell
2,100
-1,500
-42% -$3.27K ﹤0.01% 3646
2022
Q2
$8K Sell
3,600
-1,859
-34% -$8.84K ﹤0.01% 3268
2022
Q1
$37K Buy
5,459
+59
+1% +$625 ﹤0.01% 2448
2021
Q4
$85K Hold
5,400
﹤0.01% 2009
2021
Q3
$108K Hold
5,400
﹤0.01% 1832
2021
Q2
$166K Buy
+5,400
New +$162K ﹤0.01% 1580

Other funds holding RNLX

Rockefeller Capital Management's RNLX Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2023, closing a stake of 2,100 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in RNLX in Q2 2021 and held it in 7 quarters. The position peaked at $166K in Q2 2021. 18 funds tracked by Wall St. Rank hold RNLX as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 2,100 Renalytix plc American Depositary Shares shares in Q1 2023, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Renalytix plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
  • Rockefeller Capital Management's Renalytix plc American Depositary Shares position peaked at $166K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.